Prognostic factors in cutaneous melanoma - towards a more personalized risk stratification
Description: Popular science description: The project has two parts. To investigate: I) Phenotypes and lifestyle factors in relation to mortality after melanoma diagnosis; II) Trends in melanoma incidence and survival in Norway in 1983-2019. In part I, we use data from the unique large Norwegian Women and Cancer cohort linked to the Cancer Registry of Norway. Sun exposure is the major environmental risk factor of melanoma, and nevi, ability to tan, and hair, eye and skin colour are important phenotypes. However, little is known about these factors and prognosis after melanoma diagnosis. In our study of nevi and pigmentation factors in relation to melanoma-specific mortality, we included women diagnosed with tumours >1.0 mm to ensure that increased melanoma awareness would not affect the results. The results suggest that lighter pigmentation and having nevi may be associated with lower melanoma-specific mortality. Physical activity is a lifestyle factor associated with reduced mortality in cancer patients, but it has been less studied for melanoma. Our results indicate that physical activity prior to melanoma diagnosis may reduce mortality. In part II, we use nationwide data from the Cancer Registry of Norway for 1983-2019. Tumour thickness at the time of diagnosis is the most important prognostic factor in first primary melanoma. Investigating trends in melanoma incidence by tumour thickness is essential to understanding and preventing melanoma. Furthermore, understanding trends in melanoma survival and mortality by tumour thickness is useful for the patients and clinicians, and in health-care planning. We have found substantial increase in thin melanomas (up to 1.0 mm), and a steady increase in the incidence of thick melanoma. These results highlight the necessity for increased awareness of new, rapidly growing pigmented lesions in older adults, particularly men.
Project summary: Norway is ranked third worldwide in cutaneous melanoma (CM) incidence, mortality and disability-adjusted life years. Prognostic factors and risk stratification after CM diagnosis is important. 1) Little is understood whether patients with high risk pigmentary characteristics and many nevi develop more aggressive CM than those without such features. Whether sun exposure has a role in CM survival is controversial. The few available studies have suggested a protective role, the opposite or no association, creating a paradox that the known carcinogen ultraviolet radiation (UVR) can act as a survival enhancer, confusing to physicians and patients. In a unique population-based cohort, we will study pigmentary characteristics, nevi and recent and lifetime UVR exposure as prognostic factors in CM. 2) Tumour thickness is the cornerstone for staging CM with consequences for estimated prognosis, patient management and follow-up. Up-to-date and accurate prognosis is essential to the patient. Identifying optimal thickness cut-points for risk stratification is crucial in the clinic. Thin CM (<1 mm) is more common and have better survival than thicker, but recent studies indicate that not only the death toll of thick but also thin CM is severe, and varies within the <1 mm category. Long follow-up is needed to study thin CMs. The high quality Cancer Registry of Norway (CRN) lacks thickness data prior to 2008. In two pilots we found that thickness is available in the CRN paper archive for 1980-2007 and retrieval is feasible, enabling establishment of a resource of 45,000 CM patients diagnosed in 1980-2018. We will take advantage of this unique Norwegian setting, establish this resource and study, overall and in important subgroups, long-term trends in tumour thickness, the mortality burden of thin and thick CMs, the success of previous (and future) prevention campaigns, and investigate tumour thickness cut-points for risk stratification to guide clinical management and follow-up.
Teaser: The project has two parts. To investigate: I) Phenotypes and lifestyle factors in relation to mortality after melanoma diagnosis; II) Trends in melanoma incidence and survival in Norway in 1983-2019. In part I, we use data from the unique large Norwegian Women and Cancer cohort linked to the Can...
Disciplines: [["Medisin og helsefag", "Klinisk medisinske fag", "Dermatologi og venereologi"]]
Geographies: [["Oslo - Oslove", "Oslo - Oslove"]]
Funder: Norges Forskningsråd
Amount: NOK 7,661,000
Funding type: research
Funder scheme: FRIPROSJEKT-FRIPROSJEKT
Start date: 2020-01-01
End date: 2026-12-31
Investigator: Marit Bragelien Veierød (lead)
Institutions: University of Oslo, UNIVERSITETET I OSLO
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Funded outputs count: 0
Funder award ID: rcn-foriss-302048
OpenAlex ID: G3705408140
